Latham & Watkins Advises Prendio and BioProcure in Its Investment From Primus Capital

Prendio, the leading provider of cloud-based (Software-as-a-Service) eProcurement software and supplier marketplace solutions for life sciences, and sister company BioProcure, the leader in procure-to-pay support services for biotech, have announced a growth equity investment from Primus Capital. Primus' investment will support continued organic growth, expansion into additional life sciences markets, and further innovation and product development. With an expansive supplier network of more than 10,000 leading suppliers, Prendio and BioProcure's integrated procure-to-pay solutions help streamline procurement processes, enhance supplier collaboration, and deliver financial innovation and efficiency for high-growth life science companies of all stages.

Latham & Watkins LLP represented Prendio and BioProcure in the transaction with a corporate deal team led by Boston partner Kristen Grannis, with associates Elizabeth Slawsby, Michael Casagrande, Dante Spurlock, and Jihoo Kim. Advice was also provided on tax matters by Washington, D.C. partner Andrea Ramezan-Jackson, with associate Pierce Pandolph; on benefits matters by Boston partner Josh Friedman; on labor matters by New York counsel Sandra Benjamin; on IP matters by Boston partner Sarah Gagan, with associate Arun Mohan; on data privacy matters by Bay Area partner Heather Deixler, with associate Mitch Bennett*; and on antitrust matters by Washington, D.C. counsel Patrick English.

*Only admitted to practice in Australia.